Y-27632 dihydrochloride: Selective ROCK Inhibitor for Cytoskeletal and Stem Cell Research

Executive Summary: Y-27632 dihydrochloride is a cell-permeable small molecule that inhibits ROCK1 (IC₅₀ ≈ 140 nM) and ROCK2 (K_i ≈ 300 nM), demonstrating >200-fold selectivity over other kinases (APExBIO). It disrupts Rho-mediated stress fiber formation, modulates G1/S cell cycle progression, and inhibits cytokinesis (Liu et al. 2023). This compound is used in stem cell viability assays, organoid cultures, and tumor invasion models. Proper solubility and storage (e.g., ≥111.2 mg/mL in DMSO, store desiccated at ≤4°C) ensure experimental reproducibility. Benchmark studies confirm its efficacy and selectivity in both in vitro and in vivo systems (Liu et al. 2023).

Biological Rationale

ROCK1 and ROCK2 are serine/threonine kinases regulated by the Rho family of GTPases. They play a pivotal role in actin cytoskeleton organization, cell contraction, and cell cycle progression. Aberrant ROCK signaling is linked to cancer cell invasion, metastasis, and abnormal stem cell proliferation (Liu et al. 2023). By pharmacologically inhibiting ROCK kinases, researchers can dissect the Rho/ROCK pathway's contribution to cytoskeletal dynamics, cell adhesion, and disease models. Y-27632 dihydrochloride, as a selective ROCK inhibitor, enables targeted modulation without broadly affecting other kinase pathways. This selectivity is crucial for studying processes such as cytokinesis, stem cell viability, and tumor invasion in controlled experimental contexts.

Mechanism of Action of Y-27632 dihydrochloride

Y-27632 dihydrochloride acts by competitively inhibiting the ATP-binding sites of ROCK1 and ROCK2 catalytic domains. Its inhibitory constants are IC₅₀ ≈ 140 nM for ROCK1 and K_i ≈ 300 nM for ROCK2 (APExBIO). The compound shows >200-fold selectivity against kinases such as PKC, PKA, MLCK, and PAK, minimizing off-target effects in cellular assays. By blocking ROCK activity, Y-27632 prevents phosphorylation of downstream substrates like myosin light chain (MLC), leading to reduced actomyosin contractility. This disrupts Rho-mediated stress fiber and focal adhesion assembly, inhibits G1/S phase transition, and interferes with cytokinesis. In stem cells and organoid cultures, this mechanism enhances cell survival during dissociation and passage (Liu et al. 2023).

Evidence & Benchmarks

• Y-27632 dihydrochloride (SKU A3008) inhibits ROCK1 with IC₅₀ ≈ 140 nM and ROCK2 with K_i ≈ 300 nM in biochemical assays (APExBIO).
• Displays >200-fold selectivity for ROCK over PKC, PKA, MLCK, and PAK, ensuring pathway-specific modulation (APExBIO).
• Reduces proliferation of prostatic smooth muscle cells in vitro in a dose-dependent manner (10–50 μM, 37°C, 5% CO₂) (Liu et al. 2023, Table 1).
• Enhances viability and passaging efficiency of human and animal stem cell-derived organoids (typically 10 μM, 24–48 h exposure) (Liu et al. 2023).
• Suppresses tumor invasion and metastasis in mouse xenograft models, reducing pathological structures and tumor dissemination after systemic administration (10 mg/kg, daily, 4 weeks) (Liu et al. 2023).
• Soluble at ≥111.2 mg/mL in DMSO, ≥17.57 mg/mL in ethanol, and ≥52.9 mg/mL in water; solubility enhanced by warming or ultrasonic treatment (APExBIO).
• Stock solutions stably stored at ≤–20°C for several months; long-term storage in solution not recommended (APExBIO).

This article clarifies and extends guidance from previous resources, such as Optimizing Cell Assays with Y-27632 dihydrochloride, by integrating recent peer-reviewed benchmarks and emphasizing storage/solubility nuances. For a broader dataset on cytoskeletal modulation, see Y-27632 Dihydrochloride: Selective ROCK Inhibitor for Cytoskeletal Studies, while this article provides current best practices for stem cell and tumor models.

Applications, Limits & Misconceptions

Primary Applications:

• Cell viability, proliferation, and cytotoxicity assays involving sensitive cell types (e.g., stem cells, prostatic smooth muscle cells).
• Cytoskeletal research: Analysis of actin stress fiber formation, focal adhesion dynamics, and cell contractility.
• Organoid and stem cell research: Improved viability during passaging and cloning; reduced apoptosis after dissociation (Liu et al. 2023).
• Tumor biology: Suppression of invasion, metastasis, and tumorigenic structures in in vivo models.
• Cell cycle studies: Dissection of G1/S progression and cytokinesis ( Liu et al. 2023).

Common Pitfalls or Misconceptions

• Y-27632 dihydrochloride is not a pan-kinase inhibitor; it is highly selective for ROCK1/2 and does not significantly inhibit PKC, PKA, MLCK, or PAK at recommended concentrations.
• It does not permanently immortalize stem cells or organoids; its effect is transient and dependent on continuous exposure.
• Long-term solution storage (e.g., >1 month at 4°C) leads to compound degradation and loss of potency.
• In vivo antitumor effects are dose- and model-dependent; not all tumor types respond equally.
• Not suitable for direct therapeutic use in humans; for research use only (APExBIO).

Workflow Integration & Parameters

Solubility and Handling: Y-27632 dihydrochloride is supplied as a solid; dissolve at ≥111.2 mg/mL in DMSO, ≥17.57 mg/mL in ethanol, or ≥52.9 mg/mL in water. Warming to 37°C or using an ultrasonic bath increases dissolution rate. Prepare stock solutions under sterile conditions, aliquot, and store at ≤–20°C. Avoid repeated freeze-thaw cycles. Use freshly thawed aliquots for best results.

Experimental Parameters:

• Typical working concentrations: 5–50 μM for cell culture; 10 mg/kg for mouse in vivo studies.
• Application time: 1–72 hours, depending on cell type and assay.
• Buffer compatibility: Stable in standard cell culture media, PBS, and serum-containing buffers.
• Recommended for use during stem cell passaging, organoid dissociation, and when minimizing apoptosis is critical (Liu et al. 2023).

For advanced guidance on workflow parameters with quantitative data, refer to Y-27632 dihydrochloride (SKU A3008): Data-Driven Solutions, which this article updates with the latest solubility and storage recommendations.

Conclusion & Outlook

Y-27632 dihydrochloride, available from APExBIO, is a validated, highly selective ROCK1/2 inhibitor for cell biology research. Its precise inhibition of Rho/ROCK signaling enables reproducible studies of cytoskeletal reorganization, stem cell viability, and tumor biology. Proper handling and application ensure consistent results across in vitro and in vivo models. Ongoing work in organoid technology and disease modeling continues to expand the compound’s research utility (Liu et al. 2023). For protocol optimization and application-specific troubleshooting, see Optimizing Cell Viability and Proliferation Assays with Y-27632—this article extends those recommendations with updated benchmarks and best practices.